Donepezil modulates nicotinic receptors of substantia nigra dopaminergic neurones

British Journal of Pharmacology

Volumn 141, Issue 4, 2004, Pages 644-652

  Di Angelantonio, Silvia ^a,c   Bernardi, Giorgio ^a,b   Mercuri, Nicola B ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acetylcholinesterase; Allosteric modulator; Alzheimer's disease; Desensitisation; Donepezil; Dopaminergic neuron; Neuronal nicotinic receptors; Parkinson's disease; Patch clamp; Vesamicol

Indexed keywords

CHOLINERGIC RECEPTOR; CHOLINESTERASE INHIBITOR; DONEPEZIL; GLASS; METHAMIDOPHOS; NICOTINE; NICOTINIC RECEPTOR; VESAMICOL;

ALZHEIMER DISEASE; AMPLITUDE MODULATION; ANIMAL CELL; ARTICLE; BRAIN REGION; BRAIN SLICE; CONTROLLED STUDY; DESENSITIZATION; DOPAMINERGIC NERVE CELL; DOSE TIME EFFECT RELATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; MEMBRANE CURRENT; MICROPIPETTE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; SYNAPTIC MEMBRANE; TIME; VOLTAGE CLAMP; ZONA COMPACTA;

ANIMALS; CHOLINESTERASE INHIBITORS; DOPAMINE; ELECTROPHYSIOLOGY; INDANS; INSECTICIDES; MEMBRANE POTENTIALS; NEURONS; NICOTINE; NICOTINIC AGONISTS; NOOTROPIC AGENTS; ORGANOTHIOPHOSPHORUS COMPOUNDS; PATCH-CLAMP TECHNIQUES; PIPERIDINES; RATS; RECEPTORS, NICOTINIC; SUBSTANTIA NIGRA; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 1842453883     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705660     Document Type: Article

References (44)

1. AARSLAND, D., LAAKE, K., LARSEN, J.P. & JANVIN, C. (2002). Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study. J. Neurol. Neurosurg. Psychiatry, 72, 708-712.
2. AKASOFU, S., KOSASA, T., KIMURA, M. & KUBOTA, A. (2003). Protective effect of donepezil in a primary culture of rat cortical neurons exposed to oxygen-glucose deprivation. Eur. J. Pharmacol., 472, 57-63.
3. ALDRIDGE, W.N. (1981). Organophosphorus compounds: molecular basis for their biological properties. Sci. Prog., 67, 131-147.
4. ALDRIDGE, W.N. & REINER, E. (1969). Acetylcholinesterase. Two types of inhibition by an organophosphorus compound: one the formation of phosphorylated enzyme and the other analogous to inhibition by substrate. Biochem. J., 115, 147-162.
5. CALABRESI, P., LACEY, M.G. & NORTH, R.A. (1989). Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br. J. Pharmacol., 98, 135-140.
6. CAMARA, A.L., BRAGA, M.F., ROCHA, E.S., SANTOS, M.D., CORTES, W.S., CINTRA, W.M., ARACAVA, Y., MAELICKE, A. & ALBUGUERGUE, E.X. (1997). Methamidophos: an anticholinesterase without significant effects on postsynaptic receptors or transmitter release. Neurotoxicology, 18, 589-602.
7. CLAPHAM, D.E. & NEHER, E. (1984). Substance P reduces acetylcholine-induced currents in isolated bovine chromaffin cells. J. Physiol., 347, 255-277.
8. DANI, J.A., RADCLIFFE, K.A. & PIDOPLICHKO, V.I. (2000). Variations in desensitization of nicotinic acetylcholine receptors from hippocampus and midbrain dopamine areas. Eur. J. Pharmacol., 393, 31-38.
9. DI ANGELANTONIO, S. & NISTRI, A. (2001). Calibration of agonist concentrations applied by pressure pulses or via rapid solution exchanger. J. Neurosci. Methods, 110, 155-161.
10. GINIATULLIN, R.A., SOKOLOVA, E.M., DI ANGELANTONIO, S., SKORINKIN, A., TALANTOVA, M.V. & NISTRI, A. (2000). Rapid relief of block by mecamylamine of neuronal nicotinic acetylcholine receptors of rat chromaffin cells in vitro: an electrophysiological and modeling study. Mol. Pharmacol., 58, 778-787.
11. GOTZ, T., KRAUSHAAR, U., GEIGER, J., LUBKE, J., BERGER, T. & JONAS, P. (1997). Functional properties of AMPA and NMDA receptors expressed in identified types of basal ganglia neurons. J. Neurosci., 17, 204-215.
12. GRILLNER, P., BONCI, A., SVENSSON, T.H., BERNARDI, G. & MERCURI, N.B. (1999). Presynaptic muscarinic (M3) receptors reduce excitatory transmission in dopamine neurons of the rat mesencephalon. Neuroscience, 91, 557-565.
13. HUGANIR, R.L. & GREENGARD, P. (1990). Regulation of neurotransmitter receptor desensitization by protein phosphorylation. Neuron, 5, 555-567.
14. KATZ, B. & THESLEFF, S. (1957). A study of the 'desensitization' produced by acetylcholine at the motor end-plate. J. Physiol. (Lond.), 138, 63-80.
15. KHIROUG, L., GINIATULLIN, R., SOKOLOVA, E., TALANTOVA, M. & NISTRI, A. (1997). Imaging of intracellular calcium during desensitization of nicotinic acetylcholine receptors of rat chromaffin cells. Br. J. Pharmacol., 122, 1323-1332.
16. KHIROUG, L., SOKOLOVA, E., GINIATULLIN, R., AFZALOV, R. & NISTRI, A. (1998). Recovery from desensitization of neuronal nicotinic acetylcholine receptors of rat chromaffin cells is modulated by intracellular calcium through distinct second messengers. J. Neurosci., 18, 2458-2466.
17. KLINK, R., DE KERCHOVE, D.A., ZOLI, M. & CHANGEUX, J.P. (2001). Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J. Neurosci., 21, 1452-1463.
18. KOSASA, T., KURIYA, Y., MATSUI, K. & YAMANISHI, Y. (2000). Inhibitory effect of orauy administrated donepezil hydrocloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats. Eur. J. Pharmacol., 389, 173-179.
19. LESTER, R.A. & DANI, J.A. (1995). Acetylcholine receptor desensitization induced by nicotine in rat medial habenula neurons. J. Neurophysiol., 74, 195-206.
20. MAELICKE, A., SCHRATTENHOLZ, A., SAMOCHOCKI, M., RADINA, M. & ALBUQUERQUE, E.X. (2000). Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease. Behav. Brain Res., 113, 199-206.
21. MANSVELDER, H.D. & MCGEHEE, D.S. (2002). Cellular and synaptic mechanisms of nicotine addiction. J. Neurobiol., 53, 606-617.
22. MCGEHEE, D.S. & ROLE, L.W. (1995). Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol., 57, 521-546.
23. MERCURI, N.B., BONCI, A., CALABRESI, P., STEFANI, A. & BERNARDI, G. (1995). Properties of the hyperpolarization-activated cation current Ih in rat midbrain dopaminergic neurons. Eur. J. Neurosci., 7, 462-469.
24. MORI, T., ZHAO, X., ZUO, Y., AISTRUP, G.L., NISHIKAWA, K., MARSZALEC, W., YEH, J.Z. & NARAHASHI, T. (2001). Modulation of neuronal nicotinic acetylcholine receptors by halothane in rat cortical neurons. Mol. Pharmacol., 59, 732-743.
25. NEHER, E. & STEINBACH, J.H. (1978). Local anaesthetics transiently block currents through single acetylcholine-receptor channels. J. Physiol., 277, 153-176.
26. OGURA, H., KOSASA, T., KURIYA, Y. & YAMANISHI, Y. (2000). Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. Methods Find. Exp. Clin. Pharmacol., 22, 609-613.
27. PALMER, A.M. (2002). Pharmacotherapy for Alzheimer's disease: progress and prospects. Trends Pharmacol. Sci., 23, 426-433.
28. PATERSON, D. & NORDBERG, A. (2000). Neuronal nicotinic receptors in the human brain. Prog. Neurobiol., 61, 75-111.
29. PEREIRA, E.F., HILMAS, C., SANTOS, M.D., ALKONDON, M., MAELICKE, A. & ALBUQUERQUE, E.X. (2002). Unconventional ligands and modulators of nicotinic receptors. J. Neurobiol., 53, 479-500.
30. PERRY, E.K., MORRIS, C.M., COURT, J.A., CHENG, A., FAIRBAIRN, A.F., MCKEITH, I.G., IRVING, D., BROWN, A. & PERRY, R.H. (1995). Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience, 64, 385-395.
31. PICCIOTTO, M.R. & ZOLI, M. (2002). Nicotinic receptors in aging and dementia. J. Neurobiol., 53, 641-655.
32. PIDOPLICHKO, V.I., DEBIASI, M., WILLIAMS, J.T. & DANI, J.A. (1997). Nicotine activates and desensitizes midbrain dopamine neurons. Nature, 390, 401-404.
33. PRINCE, R.J., PENNINGTON, R.A. & SINE, S.M. (2002). Mechanism of tacrine block at adult human muscle nicotinic acetylcholine receptors. J. Gen. Physiol., 120, 369-393.
34. QUICK, M.W. & LESTER, R.A. (2002). Desensitization of neuronal nicotinic receptors. J. Neurobiol., 53, 457-478.
35. QUIK, M. & KULAK, J.M. (2002). Nicotine and nicotinic receptors; relevance to Parkinson's disease. Neurotoxicology, 23, 581-594.
36. SAMOCHOCKI, M., HOFFLE, A., FEHRENBACHER, A., JOSTOCK, R., LUDWIG, J., CHRISTNER, C., RADINA, M., ZERLIN, M., ULLMER, C., PEREIRA, E.F., LUBBERT, H., ALBUQUERQUE, E.X. & MAELICKE, A. (2003). Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors. J. Pharmacol. Exp. Ther., 305, 1024-1036.
37. SANTOS, M.D., ALKONDON, M., PEREIRA, E.F., ARACAVA, Y., EISENBERG, H.M., MAELICKE, A. & ALBUQUERQUE, E.X. (2002). The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system. Mol. Pharmacol., 61, 1222-1234.
38. SIMMONS, L.K., SCHUETZE, S.M. & ROLE, L.W. (1990). Substance P modulates single-channel properties of neuronal nicotinic acetylcholine receptors. Neuron, 4, 393-403.
39. SVENSSON, A.L. & NORDBERG, A. (1996). Tacrine interacts with an allosteric activator site on alpha 4 beta 2 nAChRs in M10 cells. Neuroreport, 7, 2201-2205.
40. TISEO, P.J., ROGERS, S.L. & FRIEDHOFF, L.T. (1998). Pharmacokinetic and pharmacodynamic profile of donepezil HCl following evening administration. Br. J. Clin. Pharmacol., 46, 13-18.
41. VALENTA, D.C., DOWNING, J.E. & ROLE, L.W. (1993). Peptide modulation of ACh receptor desensitization controls neurotransmitter release from chicken sympathetic neurons. J. Neurophysiol., 69, 928-942.
42. WOOLTORTON, J.R., PIDOPLICHKO, V.I., BROIDE, R.S. & DANI, J.A. (2003). Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J. Neurosci., 23, 3176-3185.
43. ZHOU, F.M., LIANG, Y. & DANI, J.A. (2001). Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat. Neurosci., 4, 1224-1229.
44. ZHOU, F.M., WILSON, C.J. & DANI, J.A. (2002). Cholinergic interneuron characteristics and nicotinic properties in the striatum. J. Neurobiol., 53, 590-605.